USANA Health Sciences, Inc.  

(Public, NYSE:USNA)   Watch this stock  
0.00 (0.00%)
May 25 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range     -
52 week 52.55 - 75.00
Open     -
Vol / Avg. 0.00/262,556.00
Mkt cap 1.58B
P/E 16.21
Div/yield     -
EPS 3.96
Shares 24.52M
Beta 1.06
Inst. own 43%
Jul 24, 2017
Q2 2017 USANA Health Sciences Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
May 3, 2017
USANA Health Sciences Inc Annual Shareholders Meeting
May 3, 2017
Q1 2017 USANA Health Sciences Inc Earnings Call - Webcast
May 2, 2017
Q1 2017 USANA Health Sciences Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Apr '17) 2016
Net profit margin 8.37% 9.94%
Operating margin 12.88% 13.78%
EBITD margin - 15.12%
Return on average assets 18.18% 22.38%
Return on average equity 25.23% 33.01%
Employees 1,788 -
CDP Score - -


3838 W Parkway Blvd
SALT LAKE CITY, UT 84120-6336
United States - Map
+1-801-9547100 (Phone)
+1-801-9569486 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


USANA Health Sciences, Inc. develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia. Its product lines include USANA Nutritionals Essentials, Optimizers, Foods, Sense-beautiful science and All Other. Its USANA Nutritionals Essentials product line includes vitamin and mineral supplements that provide a foundation of total body nutrition for every age group beginning with children of approximately one year. Its Optimizers product line consists of targeted supplements designed to meet individual health and nutritional needs. Its Sense-beautiful science product line includes science-based, personal care products that support skin and hair by providing topical nourishment, moisturization and protection.

Officers and directors

Myron W. Wentz Ph.D. Chairman, Independent Director
Age: 76
Bio & Compensation  - Reuters
Jim Brown President, Chief Operating Officer
Age: 48
Bio & Compensation  - Reuters
Kevin G. Guest Chief Executive Officer, Independent Director
Age: 54
Bio & Compensation  - Reuters
G. Douglas Hekking Chief Financial Officer
Age: 47
Bio & Compensation  - Reuters
Josh Foukas Executive Vice President - Legal
Bio & Compensation  - Reuters
Brent Neidig Executive Vice President - China
Bio & Compensation  - Reuters
Walter Noot Chief Information Officer
Age: 51
Bio & Compensation  - Reuters
Douglas Braun Chief Marketing Officer
Age: 54
Bio & Compensation  - Reuters
Robert A. Sinnott Ph.D Chief Scientific Officer
Age: 52
Bio & Compensation  - Reuters
James H. Bramble Chief Legal Officer and Corporate Secretary
Age: 47
Bio & Compensation  - Reuters